Area of research
Pulmonary and Respiratory Medicine · Biotechnology
Research interest
Research interests include Occupational and environmental lung diseases, Lung Cancer Diagnosis and Treatment, Pleural and Pulmonary Diseases, and Lung Cancer Treatments and Mutations.
Disaster on MARS2? Lessons Learned from Modern Day Outcomes of Surgery for Pleural Mesothelioma.
Shifting Patterns in Racial and Ethnic Disparities in Esophageal Cancer: A Population-Based Analysis of 60,000 Patients.
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
AI integrations with lung cancer screening: Considerations in developing AI in a public health setting
Emphysema at Baseline Low-Dose CT Lung Cancer Screening Predicts Death from Chronic Obstructive Pulmonary Disease and Cardiovascular Disease Up to 25 Years Later
Stop Canceling Surgery for Esophageal Cancer: An Analysis of Treatment Related Mortality in 60 000 Patients.
Patients With Surgically Resectable Lung Cancer Who Opt for Radiation Have Worse Outcomes.
Race, gender, and safety: exposing biases in minimally invasive lung cancer surgery research.
Long term side effects after volumetric modulated arc therapy to the pleura in patients with malignant pleural mesothelioma.
The Impact of COVID-19 Infection Prior to Lung Resection on Postoperative Complications.
Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma.
Radiologic Features of Nodules Attached to the Mediastinal or Diaphragmatic Pleura at Low-Dose CT for Lung Cancer Screening
Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Supplementary Table S2 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S4 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S5 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S1 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S6 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S3 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Table S4 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Data from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Table S1 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Table S6 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Table S3 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Figure S2 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
Supplementary Table S5 from Single-Cell View of Tumor Microenvironment Gradients in Pleural Mesothelioma
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.